期刊文献+

三阴性乳腺浸润性导管癌的MRI影像学表现 被引量:3

MR imaging of triple negative breast cancer with histological type: Invasive ductal carcinoma not otherwise specified
下载PDF
导出
摘要 目的探讨三阴性乳腺浸润性导管癌的MRI特征。方法收集2011年1月—2012年12月在3.0T MRI检查,且获得病理证实的浸润性导管癌共234例,其中三阴性乳腺癌78例、非三阴性乳腺癌156例。回顾性分析其临床及MRI资料。根据美国放射学会的乳腺报告及数据系统标准评估其MRI表现,记录病灶形态(非肿块/肿块)。若为肿块,则继续从肿块形状(圆形/卵圆形/分叶状/不规则形)、边缘(光滑/不规则/毛刺)、内部强化特征(均匀/不均匀/环形)等方面进行分析,同时记录病灶数目(单灶/多灶)。若为非肿块,则分析病灶分布形式(段样/区域样/弥漫)、内部强化特征(不均匀/点簇状/网状)。在T2WI上记录病灶信号特点(低或等/高/高亮)。采用单因素及多因素分析三阴性乳腺癌与非三阴性乳腺癌的差异。结果 78例三阴性乳腺癌中,69例为肿块样强化、9例为非肿块样强化。156例非三阴性乳腺癌中,120例为肿块样强化、36例为非肿块样强化。单因素分析显示,三阴性乳腺癌与非三阴性乳腺癌的病灶形态(P=0.035)、肿块边缘(P<0.001)、内部强化特点(P<0.001)及T2WI信号(P<0.001)差异有统计学意义,三阴性乳腺癌更多表现为肿块样强化、边缘光滑、环形强化及T2WI上高亮信号。其中边缘、内部强化特点进入回归模型,比值比(OR)分别为3.279和4.577。受试者工作特征曲线(ROC)证实,病灶表现为边缘光滑及环形强化的特点具有较高的诊断价值[曲线下面积(AUC)为0.812]。结论边缘光滑及呈环形强化的肿块样强化为三阴性浸润性导管癌较为特征的MRI表现。 Objective To evaluate the MR imaging features of invasive ductal carcinoma not otherwise specified (IDC NOS). Methods From January 2011 to December 2012, a total of 234 patients with immunohistochemically confirmed invasive ductal carcinoma not otherwise specified in our hospital were chosen, 78 with triple-negative breast cancer, and 156 with non-triple negative breast cancer. The clinical and MRI morphologic features by Breast Imaging Reporting and Data System (BI-RADS) including lesion shape (round, oval, lobulated, or irregular), margin (smooth, irregular, or spiculated), internal en- hancement pattern (homogeneous, heterogeneous, or rim enhancement), size, as well as signal intensity (low/equal, high, or bright high) on T2-weighted image (T2WI) were evaluated. Univariate and multivariate logistic regression analyses were used to predict the related factors. Results Compared with non-triple negative breast caner, mass lesion (P=0.035), smooth margin (P〈0.001), rim enhancement (P〈0.001), and very high intratumoral signal intensity on T2WI (P〈0.001) were significantly associated with triple-negative breast cancer. Smooth margin and rim enhancement entered into the regression model, with odd rate (OR) value of 3.279 and 4.577, respectively. The receiver operating characteristic curve (ROC) confirmed that mass margin combined with internal enhancement can be helpful in predicting triple-negative breast cancer (AUC=0.812). Conclusion Several MRI features such as smooth margin and rim enhancement might be used to detect triple-negative breast cancer.
出处 《肿瘤影像学》 2013年第2期170-174,共5页 Oncoradiology
关键词 磁共振成像 组织学类型 三阴性乳腺癌 Magnetic resonance imaging Histological type Triple-negative breast cancer
  • 相关文献

参考文献17

  • 1WOLFF A C,HAMMOND M E,SCHWARTZ J N. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].Journal of Clinical Oncology,2007,(01):118-145.
  • 2SEKINE I,SHIMIZU C,NISHIO K. A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer[J].International Journal of Clinical Oncology,2009,(02):112-119.
  • 3LIGRESTI G,LIBRA M,MILITELLO L. Breast cancer:molecular basis and therapeutic strategies (review)[J].Mol Med Rep,2008,(04):451-458.
  • 4UEMATSU T,KASAMI M,YUEN S. Triplenegative breast cancer:correlation between MR imaging and pathologic findings[J].Radiology,2009,(03):638-647.doi:10.1148/radiol.2503081054.
  • 5KO E S,LEE B H,KIM H A. Triple-negative breast cancer:correlation between imaging and pathological findings[J].European Journal of Radiology,2010,(05):1111-1117.
  • 6IRSHAD S,ELLIS P,TUTT A. Molecular heterogeneity of triple-negative breast cancer and its clinical implications[J].Current Opinion in Oncology,2011,(06):566-577.
  • 7MONTAGNA E,MAISONNEUVE P,ROTMENSZ N. Heterogeneity of triple-negative breast cancer:histologic subtyping to inform the outcome[J].Clinical Breast Cancer,2013,(01):31-39.
  • 8DELPECH Y,WU Y,HESS K R. Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer[J].Breast Cancer Research and Treatment,2012,(02):619-627.
  • 9SYNNESTVEDT M,BORGEN E,RUSSNES H G. Combined analysis of vascular invasion,grade,HER2and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy[J].Acta Oncologica,2013,(01):91-101.
  • 10KONTZOGLOU K,PALLA V,KARAOLANIS G. Correlation between Ki67 and breast cancer prognosis[J].Oncology(Basel),2013,(04):219-225.

同被引文献45

  • 1王跃华,王全红,李丽,肖彦增,殷卫东,杨宣琴,王丽霞,王晋芬.乳腺癌Her-2基因检测方法对比[J].临床与实验病理学杂志,2007,23(2):225-226. 被引量:11
  • 2Carey I. A,Perou C M,Livasy C A,et al. Race,breast cancer sub types,and survival in the Carolina Breast Cancer Study[J]. JA- MA,2006,295(21) :2492--2502.
  • 3Dent R, Trudeau M, Pritchard K I, et al. Triple-negative breast cancer: clinical features and patterns of reeurrence[J]. Clin Cancer Res,2007,13(15 Pt 1) :4429--4434.
  • 4Vona-Davis L, Rose D P, Hazard H, et al. Triple negative breast cancer and obesity in a rural appalachian population[J]. Cancer Epidemiol Biomarkers Prey,2008,17(12) :3319--3324.
  • 5Rakha E A,EI Sayed M E,Green A R,et al. Prognostic markers in triple negative breast cancer[J]. Cancer, 2007,109 (1) : 25-- 32.
  • 6Livasy C A, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal like subtype of invasive breast carcinoma[J]. Mod Pathol, 2006,19(2) :264--271.
  • 7Fulford L G, Easton D F, Reis Filho J S, et al. Specific morpho- logical features predictive for the basal phenotype in grade 3 inva sive duetal carcinoma of breast[J]. Histopathology, 2006,49( 1 ): 22--34.
  • 8Cleator S, Heller W,Coombes R C. Triple negative breast canc er: therapeu-tic optionsJ. Lancet Oncol,2007,8(3):235 244.
  • 9Dawood S, Broglio K, Esteva F J, et al. Survival among women with triple receptor-negative breast cancer and brain metastases [J]. Ann Oncol,2009,20(4) :621--627.
  • 10Cleator S, Heller W, Coombes R C. Triple-negative breast cans er : therapeutic options[J]. Lancet Oncol, 2007,8 (3) : 235 -- 244.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部